Application 087513
- Type
- ANDA
- Sponsor
- PHARM ASSOC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | ELIXIR;ORAL | 12.5MG/5ML | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A087513-001 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | 12.5MG/5ML | ELIXIR / ORAL | AA | RLD, RS | 1982-02-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A087513-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A087513-001 | DIPHENHYDRAMINE HYDROCHLORIDE | 12.5MG/5ML | ELIXIR / ORAL | RS | 1982-02-10 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A087513-001 | DIPHENHYDRAMINE HYDROCHLORIDE | 12.5MG/5ML | ELIXIR / ORAL | RS | 1982-02-10 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A087513-001 | DIPHENHYDRAMINE HYDROCHLORIDE | 12.5MG/5ML | ELIXIR / ORAL | RS | 1982-02-10 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A087513-001 | DIPHENHYDRAMINE HYDROCHLORIDE | 12.5MG/5ML | ELIXIR / ORAL | AA | RLD, RS | 1982-02-10 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A087513-001 | AA | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A087513-001 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A087513-001 | AA | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A087513-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diphenhydramine HCL | DIPHENHYDRAMINE HYDROCHLORIDE | Redmont Pharmaceuticals, LLC | d8944f3c-acef-4ebe-9633-7d641ae95edf | 2026-08-03 | Warnings, Adverse reactions | 087513 ANDA087513 |
| DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 6fe6fe2d-4405-4e7a-a2ed-5eb367d52842 | 2024-04-05 | Warnings, Adverse reactions | 087513 ANDA087513 0121-0978 0121-0489 |
| DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | bf7ab250-38b0-ba29-e053-2a95a90a8f32 | 2023-04-27 | Warnings, Adverse reactions | 087513 ANDA087513 71872-7242 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0121-0489 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0489 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0489 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0489 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0489 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0978 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0978 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0978 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0978 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0978 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 69067-092 | Diphen | Diphenhydramine Hydrochloride | Foxland Pharmaceuticals, Inc. | ANDA | Current |
| 69067-092 | Diphen | Diphenhydramine Hydrochloride | Foxland Pharmaceuticals, Inc. | ANDA | Current |
| 71872-7242 | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | ANDA | Current |
| 73480-150 | DI-PHEN | DIPHENHYDRAMINE HYDROCHLORIDE | TriVue Pharmaceuticals, Inc. | ANDA | Current |
| 73480-150 | DI-PHEN | DIPHENHYDRAMINE HYDROCHLORIDE | TriVue Pharmaceuticals, Inc. | ANDA | Current |